1. Home
  2. HSHP vs CCCC Comparison

HSHP vs CCCC Comparison

Compare HSHP & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HSHP
  • CCCC
  • Stock Information
  • Founded
  • HSHP 2021
  • CCCC 2015
  • Country
  • HSHP Bermuda
  • CCCC United States
  • Employees
  • HSHP N/A
  • CCCC N/A
  • Industry
  • HSHP
  • CCCC Biotechnology: Pharmaceutical Preparations
  • Sector
  • HSHP
  • CCCC Health Care
  • Exchange
  • HSHP Nasdaq
  • CCCC Nasdaq
  • Market Cap
  • HSHP 248.0M
  • CCCC 244.9M
  • IPO Year
  • HSHP 2023
  • CCCC 2020
  • Fundamental
  • Price
  • HSHP $4.59
  • CCCC $1.25
  • Analyst Decision
  • HSHP
  • CCCC Buy
  • Analyst Count
  • HSHP 0
  • CCCC 4
  • Target Price
  • HSHP N/A
  • CCCC $12.50
  • AVG Volume (30 Days)
  • HSHP 223.2K
  • CCCC 1.1M
  • Earning Date
  • HSHP 05-20-2025
  • CCCC 05-07-2025
  • Dividend Yield
  • HSHP 10.15%
  • CCCC N/A
  • EPS Growth
  • HSHP 1123.58
  • CCCC N/A
  • EPS
  • HSHP 0.48
  • CCCC N/A
  • Revenue
  • HSHP $123,580,000.00
  • CCCC $35,584,000.00
  • Revenue This Year
  • HSHP $11.04
  • CCCC N/A
  • Revenue Next Year
  • HSHP $26.01
  • CCCC $36.31
  • P/E Ratio
  • HSHP $10.12
  • CCCC N/A
  • Revenue Growth
  • HSHP 236.40
  • CCCC 71.44
  • 52 Week Low
  • HSHP $4.29
  • CCCC $1.09
  • 52 Week High
  • HSHP $9.76
  • CCCC $7.66
  • Technical
  • Relative Strength Index (RSI)
  • HSHP 37.02
  • CCCC 32.58
  • Support Level
  • HSHP $4.48
  • CCCC $1.09
  • Resistance Level
  • HSHP $4.84
  • CCCC $1.32
  • Average True Range (ATR)
  • HSHP 0.25
  • CCCC 0.15
  • MACD
  • HSHP -0.07
  • CCCC 0.02
  • Stochastic Oscillator
  • HSHP 20.83
  • CCCC 25.58

About HSHP Himalaya Shipping Ltd.

Himalaya Shipping Ltd is an independent dry bulk company that focuses on owning and operating its Newcastlemax dry bulk carriers.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a biopharmaceutical company advancing targeted protein degradation science to develop a new generation of small-molecular medicines to transform how the disease is treated. Its TORPEDO platform enables the discovery of a new class of targeted investigational small-molecule medicines called protein degraders.

Share on Social Networks: